Local board-certified dermatologist Louis Kuchnir, MD, FAAD, was honored as an American Academy of Dermatology Patient Care Hero for establishing a COVID-19 vaccination site in Marlborough, Mass. for school nurses at a time early in the vaccine rollout when vaccines were in short supply.
Local board-certified dermatologist Amy J. Derick, MD, FAAD, was honored as a Patient Care Hero by the American Academy of Dermatology for her efforts to improve access to COVID-19 vaccines for frontline health care professionals in Illinois after realizing they could not obtain vaccinations at the start of the vaccine rollout in December 2020 and January 2021.
A UCLA team has developed a predictive model that pinpoints which populations in which neighborhoods of Los Angeles County are most at risk from COVID-19, and, by extension, which should be prioritized for vaccines. The work is applicable nationally.
One-quarter of people who take the drug methotrexate for common immune system disorders — from rheumatoid arthritis to multiple sclerosis — mount a weaker immune response to a COVID-19 vaccine, a new study shows.
A team of researchers from universities in California and Texas has found immunization rates for children in Texas for a wide range of diseases, including polio and measles, have dropped steeply during the COVID-19 pandemic.
Research published by JAMA Network Open shows how non-pharmaceutical interventions (NPIs) like mask wearing and physical distancing can help prevent spikes in COVID-19 cases as populations continue to get vaccinated.
Researchers at Penn State College of Medicine are participating in a national clinical trial evaluating whether people who have previously experienced severe allergic reactions are at increased risk for an immediate, systemic allergic reaction to the Moderna or Pfizer-BioNTech COVID-19 vaccines.
UAB has established an interdisciplinary hub for research and patient care in the study of immunity.
Antibodies aren’t the only immune cells needed to fight off COVID-19 — T cells are equally important and can step up to do the job when antibodies are depleted, suggests a new Penn Medicine study of blood cancer patients with COVID-19 published in Nature Medicine.
In a new study, scientists at The Hong Kong University of Science and Technology (HKUST) have revealed that most T cell epitopes known to be targeted upon natural infection are seemingly unaffected by current SARS-CoV-2 variants.
A new study looking across a large body of research finds further evidence for the safety of vaccines that are Food and Drug Administration-approved and routinely recommended for children, adults and pregnant women.
A team of researchers, led by a University of Minnesota associate professor, have developed a polymer “wafer” that, when placed under the tongue, can effectively deliver and preserve protein-based vaccines for diseases. The research could open the door for vaccines that can be more easily produced and distributed to communities around the world.
In an interview in the French documentary "Hold-Up," Luc Montagnier, a French virologist and recipient of the 2008 Nobel Prize in Medicine for his discovery of the human immunodeficiency virus (HIV), claimed that Covid-19 vaccines are creating new variants in various parts of the world. He believes that the ongoing vaccinations across the world is an ”enormous mistake.” ”The history books will show that because it is the vaccination that is creating the variants.” Multiple French social media posts that have been shared by thousands have also claimed that COVID-19 vaccines are causing variants of the virus to emerge. We find these claims to be false. There is no evidence the vaccines are creating more variants.
A coalition of six U.S. subsidiary companies have sponsored a COVID-19 mobile clinic to vaccinate 10,000 maquiladora workers employed in Baja California, Mexico. UC San Diego Health is vaccinating about 1,500 workers daily.
On 17 May 2021, the UK moved to step three of the Government's Roadmap out of Lockdown - which allowed for the lifting of a ban on foreign travel.
For many, the arrival of COVID-19 mRNA vaccines in less than a year is, quite literally, unbelievable. That skepticism feeds hesitancy to take the vaccines. But development of mRNA vaccines against COVID-19 is no overnight success. In fact, they have a remarkable backstory stretching back decades.
The University of Illinois Chicago has been selected by the National Institutes of Health as the principal site of a multi-center collaborative in the Chicago area that will bolster research and outreach to help communities disproportionately affected by COVID-19.
The discovery of new possible biomarkers to predict clinical and immune responses to dengue virus infection could be critical to informing future vaccines for the mosquito-borne virus, which saw a record number of over 400 million cases in 2019.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right